Market Research Logo

Hungary Pharmaceuticals & Healthcare Q4 2018

Hungary Pharmaceuticals & Healthcare Q4 2018

Key View:

Hungary's underfunded healthcare system will undermine the performance of the pharmaceutical sector over ourforecast period. Poor policy has resulted in pharmaceutical prices rising significantly above EU averages, placing pressure on thepublic healthcare budget. The burden of medicine costs is likely to continue to shift onto household, reducing their affordability andtherefore dampening medicine demand. Unless the Hungarian government makes radical changes to financing the healthcaresystem, multinational pharmaceutical firms will face minimal growth opportunities in the coming years.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Hungary Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Egis Pharmaceuticals (Servier)
Gedeon Richter
Hungary Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report